Showing results (611-620 of 688) with videos related to

Sort By:
Pageof 69
Liver International : Official Journal of the International Association for the Study of the Liver|October 17, 2015
Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patientsGregory T Everson, Karen D Sims, Paul J Thuluvath, et al.
Gastroenterology|April 29, 2015
Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade DysplasiaAaron J Small, James L Araujo, Cadman L Leggett, et al.
Gut Microbes|August 22, 2025
Increased reflux secondary bile acids are associated with changes to the microbiome and transcriptome in Barrett's esophagusCeylan Tanes, Yun Li, Gary W Falk, et al.
Pancreas|April 28, 2018
The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases WorkshopJames L Abbruzzese, Dana K Andersen, Carl A K Borrebaeck, et al.
Scientific Reports|October 30, 2021
Patient-derived organoids as a platform for modeling a patient's response to chemoradiotherapy in esophageal cancerTatiana A Karakasheva, Joel T Gabre, Uma M Sachdeva, et al.
The Journal of Clinical Investigation|March 5, 2014
SOX2 and p63 colocalize at genetic loci in squamous cell carcinomasHideo Watanabe, Qiuping Ma, Shouyong Peng, et al.
JAMA Oncology|July 3, 2024
Pancreatic Cancer Surveillance and Survival of High-Risk IndividualsAmanda L Blackford, Marcia Irene Canto, Mohamad Dbouk, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 30, 2021
COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individualsBryson W Katona, Nadim Mahmud, Mohamad Dbouk, et al.
Gastroenterology|February 5, 2023
SOX9 Modulates the Transformation of Gastric Stem Cells Through Biased Symmetric Cell DivisionQiyue Chen, Kai Weng, Mi Lin, et al.
Gastroenterology|November 5, 2013
Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infectionGregory T Everson, Karen D Sims, Maribel Rodriguez-Torres, et al.
Pageof 69